Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 235

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Advances and highlights in biomarkers of allergic diseases

Open access
Ogulur, Ismail, Pat, Yagiz, Ardicli, Ozge, Barletta, Elena, Cevhertas, Lacin, Fernandez‐Santamaria, Ruben, Huang, Mengting, Bel Imam, Manal, Koch, Jana, Ma, Siyuan, Maurer, Debbie J., Mitamura, Yasutaka, Peng, Yaqi, Radzikowska, Urszula, Rinaldi, Arturo O., Rodriguez‐Coira, Juan, Satitsuksanoa, Pattraporn, Schneider, Stephan R., Wallimann, Alexandra, Zhakparov, Damir, Ziadlou, Reihane, Brüggen, Marie‐Charlotte, van de Veen, Willem, Sokolowska, Milena, Baerenfaller, Katja, Zhang, Luo, Akdis, Mubeccel, Akdis, Cezmi A. · 2021 · Allergy

Abstract

During the past years, there has been a global outbreak of allergic diseases, presenting a considerable medical and socioeconomical burden. A large fraction of allergic diseases is characterized by a type 2 immune response involving Th2 cells, type 2 innate lymphoid cells, eosinophils, mast cells, and M2 macrophages. Biomarkers are valuable parameters for precision medicine as they provide information on the disease endotypes, clusters, precision diagnoses, identification of therapeutic targets, and monitoring of treatment efficacies. The availability of powerful omics technologies, together with integrated data analysis and network‐based approaches can help the identification of clinically useful biomarkers. These biomarkers need to be accurately quantified using robust and reproducible methods, such as reliable and point‐of‐care systems. Ideally, samples should be collected using quick, cost‐efficient and noninvasive methods. In recent years, a plethora of research has been directed toward finding novel biomarkers of allergic diseases. Promising biomarkers of type 2 allergic diseases include sputum eosinophils, serum periostin and exhaled nitric oxide. Several other biomarkers, such as pro‐inflammatory mediators, miRNAs, eicosanoid molecules, epithelial barrier integrity, and microbiota changes are useful for diagnosis and monitoring of allergic diseases and can be quantified in serum, body fluids and exhaled air. Herein, we review recent studies on biomarkers for the diagnosis and treatment of asthma, chronic urticaria, atopic dermatitis, allergic rhinitis, chronic rhinosinusitis, food allergies, anaphylaxis, drug hypersensitivity and allergen immunotherapy. In addition, we discuss COVID‐19 and allergic diseases within the perspective of biomarkers and recommendations on the management of allergic and asthmatic patients during the COVID‐19 pandemic.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/all.15089

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 235

Metadata

Authors
Ogulur, I., Pat, Y., Ardicli, O., Barletta, E., Cevhertas, L., Fernandez‐Santamaria, R., Huang, M., Bel Imam, M., Koch, J., Ma, S., Maurer, D. J., Mitamura, Y., Peng, Y., Radzikowska, U., Rinaldi, A. O., Rodriguez‐Coira, J., Satitsuksanoa, P., Schneider, S. R., Wallimann, A., Zhakparov, D., Ziadlou, R., Brüggen, M., van de Veen, W., Sokolowska, M., Baerenfaller, K., Zhang, L., Akdis, M., & Akdis, C. A.
Venue
Allergy
Publisher
Wiley
Published
2021-09-27
Volume
76
Issue
12
Pages
3659-3686
ISSN
  • 0105-4538 (ISSN-L)
  • 1398-9995
OpenAlex
W3176275668
Cited by
235
References
4
FWCI
17.23
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Advances and highlights in biomarkers of allergic diseases. https://app.cochat.ai/papers/10.1111/all.15089
The paper
Ogulur, I., Pat, Y., Ardicli, O., Barletta, E., Cevhertas, L., Fernandez‐Santamaria, R., Huang, M., Bel Imam, M., Koch, J., Ma, S., Maurer, D. J., Mitamura, Y., Peng, Y., Radzikowska, U., Rinaldi, A. O., Rodriguez‐Coira, J., Satitsuksanoa, P., Schneider, S. R., Wallimann, A., . . . Akdis, C. A. (2021). Advances and highlights in biomarkers of allergic diseases. Allergy. https://doi.org/10.1111/all.15089

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.